Xiangyu Medical Co.,Ltd (SHA:688626)
36.97
-1.07 (-2.81%)
Sep 11, 2026, 3:00 PM CST
Xiangyu Medical Co.,Ltd Revenue
Xiangyu Medical Co.,Ltd had revenue of 180.09M CNY in the quarter ending June 30, 2026, with 4.10% growth. This brings the company's revenue in the last twelve months to 781.87M, up 2.24% year-over-year. In the year 2025, Xiangyu Medical Co.,Ltd had annual revenue of 767.75M with 3.26% growth.
Revenue (ttm)
781.87M
Revenue Growth
+2.24%
P/S Ratio
7.38
Revenue / Employee
356.20K
Employees
2,195
Market Cap
5.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 767.75M | 24.22M | 3.26% |
| Dec 31, 2024 | 743.53M | -1.28M | -0.17% |
| Dec 31, 2023 | 744.81M | 256.28M | 52.46% |
| Dec 31, 2022 | 488.53M | -34.97M | -6.68% |
| Dec 31, 2021 | 523.50M | 27.98M | 5.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Edan Instruments | 2.11B |
| INKON Life Technology | 2.06B |
| Shenzhen YHLO Biotech | 1.89B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.88B |
| BMC Medical | 1.38B |
| Beijing Wandong Medical Technology | 1.38B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |